MX9102702A - Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas. - Google Patents

Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas.

Info

Publication number
MX9102702A
MX9102702A MX9102702A MX9102702A MX9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A MX 9102702 A MX9102702 A MX 9102702A
Authority
MX
Mexico
Prior art keywords
interfered
proliferative
lung diseases
oral inhalation
treat asthma
Prior art date
Application number
MX9102702A
Other languages
English (en)
Spanish (es)
Inventor
Robert J Spiegel
Francis M Cuss
Keith B Nolop
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9102702A publication Critical patent/MX9102702A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9102702A 1990-12-21 1991-12-19 Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas. MX9102702A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63155290A 1990-12-21 1990-12-21
US63156590A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
MX9102702A true MX9102702A (es) 1992-06-01

Family

ID=27091422

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102702A MX9102702A (es) 1990-12-21 1991-12-19 Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas.

Country Status (6)

Country Link
AU (1) AU9132091A (pt)
IE (1) IE914444A1 (pt)
IL (1) IL100415A0 (pt)
MX (1) MX9102702A (pt)
PT (1) PT99837A (pt)
WO (1) WO1992011025A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2265838A1 (en) 1996-09-12 1998-03-19 Alain Rolland Compositions and methods for pulmonary gene delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028422A (en) * 1986-05-27 1991-07-02 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
IE62318B1 (en) * 1986-05-27 1995-01-25 Schering Corp Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE83381T1 (de) * 1986-10-22 1993-01-15 Schering Corp Verwendung von rekombiniertem menschlichem alpha- interferon zur herstellung eines arzneimittels zur behandlung des aids-virus.
EP0294160A1 (en) * 1987-06-02 1988-12-07 Schering Corporation Treatment of chronic type b hepatitis with a combination of recombinant human alpha and gamma interferons
ZA895010B (en) * 1988-07-05 1990-03-28 Schering Corp Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferion
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
KR950011889B1 (ko) * 1988-12-01 1995-10-12 쉐링 코포레이션 정제된 재조합 사람 α-2 인터페론을 포함하는, 편평세포암 치료에 유용한 병소내 투여용 약제학적 조성물

Also Published As

Publication number Publication date
PT99837A (pt) 1992-12-31
IE914444A1 (en) 1992-07-01
WO1992011025A2 (en) 1992-07-09
IL100415A0 (en) 1992-09-06
AU9132091A (en) 1992-07-22
WO1992011025A3 (en) 1992-09-17

Similar Documents

Publication Publication Date Title
DK479189D0 (da) Inhalator
TR199501635A1 (tr) Solunum yolu ile alinan terapötik preparatlar.
NO921110D0 (no) Inhalator
DE3888838T2 (de) Atemschutzmaske.
DE59000161D1 (de) Atemschutzmaske.
HUP0101293A3 (en) Aspb28-human insulin comprising pharmaceutical composition administered by inhalation and their use
DE69003923T2 (de) Inhalator und Schutzbehälter.
IL78913A (en) Synthetic vaccines for foot and mouth disease,their preparation and use
DE3369682D1 (en) 2-substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments
NO893062D0 (no) Anvendelse av isokinolinforbindelser, saerlig i inhalasjonspreparater.
ATE271852T1 (de) Verbesserte inhalationspräparate
IL65184A (en) Preparation comprising glycyrrhizin for the treatment of dermal,including oral diseases
MX9102702A (es) Administracion de alfa interferon mediante inhalacion oral para tratar asma y enfermedades pulmonarias proliferativas, no malignas.
MX9102512A (es) Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.
ZA816417B (en) Pharmaceutical composition,especially for treating infectious diseases of the respiratory tract
DE59203456D1 (de) Flüchtige Inhalationsnarkotika enthaltende Liposomen, ihre Herstellung und Verwendung.
DE3865818D1 (de) Arzneizubereitung fuer inhalatorische anwendungen.
JPS57176949A (en) Novel carnitine derivative, manufacture and remedy for burn, epythelial disease and respiratory disease
FI963753A0 (fi) Uusi lääke hengitysteiden virustaudin hoitamiseksi
ZA919959B (en) Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
KR890004440U (ko) 분체흡입 방지 마스크
ITFI920029U1 (it) Inalatore per addurre aria da inspirare, per impiego in presenza di atmosfere nocive.
NO932380D0 (no) Inhalator
SE9603354D0 (sv) Powder inhaler IV
FR2659859B1 (fr) Inhalateur individuel de poche.